Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165542 · ClinicalTrials.gov registry record
A-protein Levels in Adult and Pediatric Brain Tumor Patients
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 54
- Enrollment target
NCT00165542 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 54 participants.
The verdict
NCT00165542 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the sensitivity and specificity of "A-PROTEIN" levels in patients with brain tumors. A-PROTEIN levels will be analyzed both pre and post treatment. Levels in blood and/or cerebrospinal fluid (CSF) will be analyzed and correlated with the underlying diagnosis and outcome.
Interventions
- OTHER A PROTEIN level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 1998-06 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00165542
The ClinicalTrials.gov registry entry for NCT00165542 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A PROTEIN level is the first listed.
NCT00165542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00165542 about?
NCT00165542 is a clinical study titled "A-protein Levels in Adult and Pediatric Brain Tumor Patients". The purpose of this study is to evaluate the sensitivity and specificity of "A-PROTEIN" levels in patients with brain tumors. A-PROTEIN levels will be analyzed both pre and post treatment. Levels in blood and/or cerebrospinal fluid (CSF) will be analyzed and correlated with the underlying diagnosis ...
What is the current status of trial NCT00165542?
This trial is currently completed. The enrollment target is 54 participants. The study started on 1998-06. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00165542?
The interventions under investigation include: A PROTEIN level (OTHER).
Who is sponsoring clinical trial NCT00165542?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.